OAM
BEAT

Oxford Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Oxford Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-106,908
Closed -$3.1M – 1853
2017
Q1 		$3.1M Sell
106,908
-4,324
-4% -$107K 0.08% 276
2016
Q4 		$2.49M Sell
111,232
-90,466
-45% -$1.77M 0.09% 258
2016
Q3 		$3.75M Buy
201,698
+88,694
+78% +$1.67M 0.12% 215
2016
Q2 		$1.84M Buy
+113,004
New +$1.66M 0.06% 389

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Oxford Asset Management's BEAT Position: Q2 2017 in Review

Oxford Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q2 2017, closing a stake of 106,908 shares — an estimated $3.1M sold.

Oxford Asset Management first reported a position in BEAT in Q2 2016 and held it in 4 quarters. The position peaked at $3.75M in Q3 2016. 195 funds tracked by Wall St. Rank hold BEAT as of Q2 2017.

  • Oxford Asset Management reported no remaining BioTelemetry, Inc. position as of Q2 2017 after selling out during the quarter.
  • Oxford Asset Management sold 106,908 BioTelemetry, Inc. shares in Q2 2017, an estimated $3.1M.
  • Oxford Asset Management first reported a position in BioTelemetry, Inc. in Q2 2016 and held it in 4 quarters.
  • Oxford Asset Management's BioTelemetry, Inc. position peaked at $3.75M in Q3 2016.
  • 195 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2017.

Based on Oxford Asset Management's 13F filing for Q2 2017, filed 11 Aug 2017.